HIFU Treatment does not involve surgery but instead uses a High Intensity Focused Ultrasound (HIFU) beam which safely and effectively destroys the prostate tissue with minimal side effects.
After reviewing the information on this website, you and your family will have a better understanding of prostate cancer treatment options and whether Ablatherm HIFU may be the right prostate cancer treatment for you.
In November 2015, the FDA granted full approval to EDAP Ablatherm HIFU to carry out prostate ablation treatment in the USA. Learn more about the FDA Approval.
CMS recently announced the acceptance of a Medicare C-code application for HIFU prostate tissue ablation, which will go into effect on July 1st, 2017. This code may be applied to any procedure performed with Ablatherm, including focal, hemi-gland, whole-gland, primary or salvage HIFU prostate ablations. Hospitals offering these HIFU procedures to Medicare patients will be eligible for reimbursement.